Employees: NN (None)Legal category: 5785Size: PMECreation date: 2012-12-17 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ISSY-LES-MOULINEAUX (92130), Hauts-de-Seine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BENDAYAN : revenue, balance sheet and financial ratios
PHARMACIE BENDAYAN is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ISSY-LES-MOULINEAUX (92130),
this company of category PME
shows in 2020 a net income positive of 67 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BENDAYAN (SIREN 789619319)
Indicator
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
66 619 €
48 927 €
85 032 €
42 553 €
39 632 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2020, PHARMACIE BENDAYAN generates positive net income of 67 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2020: 40 k€ -> 67 k€.
Net income (2020)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
66 619 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 39%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2020)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
38.681%
Financial autonomy (2020)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
57.971%
Asset age ratio (2020)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
Debt ratio
173.501
120.448
77.346
56.346
38.681
Financial autonomy
25.691
34.412
44.561
50.898
57.971
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
38.682020
2018
2019
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Good-10 pts over 3 years
In 2020, the debt ratio of PHARMACIE BENDAYAN (38.68) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
57.97%2020
2018
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Good+12 pts over 3 years
In 2020, the financial autonomy of PHARMACIE BENDAYAN (58.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 286.80. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2020)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
286.795
Liquidity indicators evolution PHARMACIE BENDAYAN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
Liquidity ratio
168.413
203.894
215.141
258.114
286.795
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
286.82020
2018
2019
2020
Q1: 133.13
Med: 181.9
Q3: 251.9
Excellent
In 2020, the liquidity ratio of PHARMACIE BENDAYAN (286.80) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE BENDAYAN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 180 transactions of similar company sales
in 2020,
the value of PHARMACIE BENDAYAN is estimated at
941 503 €
(range 627 781€ - 1 270 342€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2020
180 transactions
627k€941k€1270k€
941 503 €Range: 627 781€ - 1 270 342€
NAF 5 année 2020
Valuation method used
Net Income Multiple
66 619 €
×
14.1x
=941 504 €
Range: 627 781€ - 1 270 342€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BENDAYAN with other companies in the same sector:
Frequently asked questions about PHARMACIE BENDAYAN
What is the revenue of PHARMACIE BENDAYAN ?
The revenue of PHARMACIE BENDAYAN is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE BENDAYAN profitable?
Yes, PHARMACIE BENDAYAN generated a net profit of 67 k€ in 2020.
Where is the headquarters of PHARMACIE BENDAYAN ?
The headquarters of PHARMACIE BENDAYAN is located in ISSY-LES-MOULINEAUX (92130), in the department Hauts-de-Seine.
Where to find the tax return of PHARMACIE BENDAYAN ?
The tax return of PHARMACIE BENDAYAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BENDAYAN operate?
PHARMACIE BENDAYAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart